aod9604 human clinical trial results weight loss efficacy Fat Burner - Peptides for Visceral Fat & Metabolism AOD-9604 vs MOTS-c vs Tesamorelin

Nature 508(7495):258-262

Metabolic research focus: Studied in obese rodent models for effects on fat oxidation, weight gain trends, and markers linked to fat breakdown and storage

While oral bioavailability is lower than subcutaneous administration, these studies established that even high oral doses maintained excellent safety profiles, though higher doses (54 mg) were associated with increased gastrointestinal discomfort

If you want the bigger picture of supervised care, our overview of what medically supervised peptide therapy in Miami actually involves, from the first evaluation through a monitored, adjustable plan explains how that works

Research in animal models has shown sustained reductions in body weight gain and increased fat oxidation over extended treatment periods, with individual results varying considerably based on adherence to diet and exercise protocols alongside peptide use